Hans-Peter Kiem, MD, PhD

Dr. Hans-Peter Kiem is an expert in hematopoietic stem cell (HSC) biology, transplantation and cell and gene therapy. His focus has been the development of improved HSC gene therapy and genome editing approaches for the treatment of patients with genetic and infectious diseases or cancer. His lab has described a refined HSC population for improved HSC engineering and targeting. A major recent focus has been the development of in vivo gene therapy approaches to make HSC gene therapy and immunotherapy more portable and more widely accessible also in low-and middle-income countries. He has had continuous NIH funding for the past 25 years and has published more than 350 manuscripts. Dr. Kiem has extensive experience training students, postdoctoral fellows and junior faculty and has mentored more than 100 trainees over the past 25 years. He is a Professor and Deputy Director of the Translational Science and Therapeutics Division and Director of the Stem Cell and Gene Therapy Program at Fred Hutchinson Cancer Center. He is also a Professor of Medicine and Pathology at the University of Washington. He has served on many ASGCT scientific and educational committees and in 2020 he was elected to the Executive Committee serving as president of ASGCT from May 2022 to May 2023.